Expanding Horizons: Emerging Applications in the Medical Display Market https://www.marketsandmarkets.com/Market-Reports/medical-display-market-74058413.html The global Medical Display Market is projected to reach USD 2.9 billion by 2028 from USD 2.3 billion in 2023, at a CAGR of 5.2% during the forecast period. There are several factors which drive the medical display market like rising technological advancements, increasing demand for diagnostic imaging, rising awareness and adoption of minimally invasive procedures and surge in telemedicine and remote diagnostics. The market for Medical Display is dominated by companies like Barco NV (Belgium), Eizo (Japan), Sony Electronics Inc. (Japan), Lg Electronics (South Korea), Novanta (US), FSN Medical Technologies (South Korea), Advantech (Taiwan), Quest International (US), Steris (UK), Jusha Medical (China), Siemens Healthineers Ag (Germany), Double Black Imaging (US), HP Development Co. Ltd (US), Stryker (US), and Coje Display (South Korea)

Driving Forces and Growth Prospects in Multiplex Assays https://www.marketsandmarkets.com/Market-Reports/multiplex-assays-market-61593314.html The multiplex assays market is valued at an estimated USD 3.5 billion in 2022 and is projected to reach USD 5.3 billion by 2027, at a CAGR of 8.8% during the forecast period. Growth in this market is mainly driven by factors such as increasing use of multiplex assays in companion diagnostics and increasing advantages over singleplex and traditional assays. However, the high cost of multiplex assay equipment, stringent regulations and standards, and issues in the standardization of multiplex assays design are the major factors restraining the growth of this market. The key players in multiplex assays market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), DiaSorin S.p.A. (Italy), QIAGEN N.V. (Netherlands), Abcam plc (UK), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Quanterix (US), Bio-Techne (US), MESO SCALE DIAGNOSTICS, LLC (US), Randox Laboratories Ltd. (UK), Olink (Sweden), Seegene Inc. (South Korea), Siemens Healthcare AG (Germany), PerkinElmer Inc. (US), Shimadzu Corporation (Japan), Promega Corporation (US), Enzo Biochem Inc. (US), Cayman Chemical (US), Boster Biological Technology (US), Antigenix America, Inc. (US), Quansys Biosciences Inc. (US), and RayBiotech Life, Inc. (US).

Regulatory Landscape Analysis and Its Impact on the Veterinary API Market https://www.marketsandmarkets.com/Market-Reports/veterinary-api-market-91801752.html The Global Veterinary API Market is projected to reach USD 11.9 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.9% the forecast period. There are several factors which drive the Veterinary API Market like rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures. The veterinary API industry is anticipated to develop because of the rising demand for veterinary medicines and other animal health products. The market for Veterinary API Market is dominated by companies like Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India), Insud Pharma (Spain), Menadiona Sl (Spain), Rochem International Inc. (US), and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China)

Regulatory Landscape Analysis and Its Impact on the Adhesion Barrier Market https://www.marketsandmarkets.com/Market-Reports/adhesion-barrier-market-208132543.html The global adhesion barrier market size is projected to reach USD 0.9 billion by 2028 from USD 0.7 billion in 2023, at a CAGR of 7.4% during the forecast period. The increasing volume of surgeries and sports-related injuries, rising geriatric population, and the increasing awareness about adhesion formation and adhesion-related diseases are the major factors driving the growth of this market. On the other hand, the reluctance towards the usage of adhesion barriers amongst surgeons is expected to restrain the growth of this market during the forecast period. The untapped emerging markets will offer lucrative opportunities to the companies offering in adhesion barrier market.

Impact on the Mass Spectrometry Market https://www.marketsandmarkets.com/Market-Reports/mass-spectrometry-market-437.html The global mass spectrometry market is projected to reach USD 7.8 billion by 2028 from USD 5.4 billion in 2023, growing at a CAGR of 7.5% during the forecast period. Increasing spending on pharmaceutical R&D primarily drives the growth of this market in mass spectrometry, government regulations on drug safety, growing focus on the quality of food products further supports the market growth. However, recession impact impedes the market growth. The mass spectrometry business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global mass spectrometry market are SCIEX AB (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Waters Corporation(US), PerkinElmer Inc. (US), Shimadzu Corporation (Japan) and Bruker Corporation (US) among others.